Condition

WHO Grade II Glioma clinical trials and research

As of November 12, 2026, Find a Trial lists 3 WHO Grade II Glioma clinical trials that are recruiting, in United States. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest WHO Grade II Glioma clinical trials

StudyPhaseWhereStatusRegistered
Chemotherapy and radiation therapy for treating certain types of gliomas Phase 2 Houston, Texas Recruiting Nov 10, 2020
Using advanced MRI techniques to evaluate lower grade gliomas Phase 1 San Francisco, California Recruiting Sep 7, 2020
Customized video to reduce anxiety for brain tumor patients and caregivers during radiation treatment — Houston, Texas Recruiting Jul 21, 2020

All recruiting trials (3)

Related topics

WHO Grade III GliomaGlioblastomaAnaplastic OligodendrogliomaOligodendroglioma

Quick answers

How many WHO Grade II Glioma clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.